Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

New Executive Management Board at Bender – the world's leading provider of solutions that make electrical infrastructures smart and safer

GRÜNBERG, Germany, May 8, 2025 /PRNewswire/ -- Bender Industries GmbH & Co. KG (Bender) appoints Michael Breuer as CEO and Nicole Bender as CFO. Heinz Nowicki and Dr. Sven Hartung have left the company. - Picture is available at AP

2025-05-08 01:36 2655

Minaris Advanced Therapies launches as the leading global partner dedicated to cell therapy development, manufacturing, and testing

New company unveiled at the annual ISCT conference in New Orleans combines two tenured and innovative CDMOs with a testing powerhouse PHILADELPHIA, May 7, 2025 /PRNewswire/ -- Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S...

2025-05-07 20:12 3036

AXA Partners with Hong Kong Swimming Academy Promoting Local Swimming Development and Fostering a Healthier Community

HONG KONG, May 7, 2025 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") is thrilled to announce that it has become the Principal Partner of the Hong Kong Swimming Academy (HKSA), to join forces promote the development of swimming in Hong Kong. This collaboration aims to inspire and nurture the cit...

2025-05-07 18:36 3368

AXA Partners with Hong Kong Swimming Academy Promoting Local Swimming Development and Fostering a Healthier Community

The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China

* The results showed that the SOFA scores of the drug treatment groups on the 7th day were significantly lower than those of the baseline, especially in the high-dose group, where the decrease was significantly greater than that in the placebo group, of which the difference was statistically si...

2025-05-07 14:19 4135

Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development

Collaboration Aims to Expand Globally Connected Scientific Dialogue and Accelerate Innovation in Human Health and Sustainability SINGAPORE, May 7, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, the Yong Loo Lin School of Medicine, National University of Singapore ...

2025-05-07 10:12 3072

Britishpedia Honours Family Podiatry Centre Founder, Mark Reyneker, As a Success Icon

SINGAPORE, May 7, 2025 /PRNewswire/ -- Mark Reyneker, founder of the Family Podiatry Centre, will be featured in the 7th Edition of Britishpedia's "Successful People in Malaysia and Singapore." He has been recognised for his significant contributions to podiatry in Singapore and Malaysia, highlig...

2025-05-07 10:00 2110

Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.

* AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody Drugs TOKYO, May 7, 2025 /PRNewswire/ -- Ajinomoto Co., Inc. (President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as "Ajinomoto") has been conducting joint resea...

2025-05-07 08:03 2437

Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.

Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema

SAN FRANCISCO and SUZHOU, China, May 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...

2025-05-07 08:00 4403

Everest Medicines Announces NMPA Full Approval of NEFECON® for the Treatment of Primary Immunoglobulin A nephropathy (IgAN) in Adults at Risk of Disease Progression

SHANGHAI, May 7, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that the supplemental New Drug Applica...

2025-05-07 07:30 3107

Cronometer Offers Free Access to Women's Health Nutrition Score This May to Help Close Australia's Nutrient Gaps

Globally trusted nutrition tracker is making its evidence-based Women's Health Nutrition Score freely available, helping Australian women take control of their long-term wellbeing REVELSTOKE, BC, May 7, 2025 /PRNewswire/ -- In support of women's health this May,Cronometer, the leading global n...

2025-05-07 05:00 2730

FutureLink Boston 2025 Reinforces TraceLink's Leadership in Supply Chain Orchestration and Innovation

BOSTON, May 7, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, successfully hosted FutureLink Boston 2025, bringing together more than 150 attendees ranging across senior executives, industry experts, and supply chain tech...

2025-05-07 00:39 2665

Plasmidsaurus Opens 10th Global Lab in Singapore, Scaling to Meet the Demand for Cutting-Edge Sequencing Around the World

SINGAPORE and SOUTH SAN FRANCISCO, Calif., May 6, 2025 /PRNewswire/ -- Plasmidsaurus, the company that sequences while you sleep, today announced the opening of its tenth global sequencing lab, located inSingapore's vibrant biomedical hub. The new site dramatically shortens turnaround times for ...

2025-05-06 23:56 3468

Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)

First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used for Completion of All Activities to Support Planned NDA Submission in the Second Half of 2025, Along with Plans for Commercialization in the U.S. MT PLEASANT, S...

2025-05-06 22:12 3434

"Gedeon Richter House of Hope" opens its doors to support 300 women annually in Africa-Bamako

BUDAPEST, Hungary, May 6, 2025 /PRNewswire/ -- A center providing healthcare and educational support as well as shelter for vulnerable women has beenbuilt in Bamako, the capital of Mali, with financial assistance from Gedeon Richter. As one of the world's leading manufacturers of women's healthca...

2025-05-06 19:01 2526

Global Survey from World Lupus Federation Finds Nearly Half of People with Lupus Report Kidney Involvement

New data highlights urgent need for improved education and diagnosis of lupus nephritis (lupus-related kidney disease), a serious complication of lupus WASHINGTON, May 6, 2025 /PRNewswire/ -- A global survey conducted by the World Lupus Federation reveals that 47% of people living with lupus rep...

2025-05-06 19:00 3130

Ascletis Announces Oral and Poster Presentations on ASC47, an Adipose-Targeted, Muscle-Preserving Weight Loss Drug Candidate for Obesity at the 32nd European Congress on Obesity

HONG KONG, May 6, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces oral and poster presentations on preliminary studies of ASC47, an adipose-targeted, muscle-preserving weight loss drug candidate for obesity, will be presented at the 32nd European Congress On Obesity (E...

2025-05-06 16:55 3346

Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy

– Round co-led by new investors, Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio, and Boehringer Ingelheim Venture Fund – Proceeds will support the Phase 1/2 clinical trial of lead candidate, NVC-001, in patients with LMNA-related d...

2025-05-06 13:00 3615

Asia Pacific Initiative on Reproduction (ASPIRE) 2025 Congress: Fatherhood role models a new focus in filling the gap between actual and desired family sizes

SINGAPORE, May 6, 2025 /PRNewswire/ -- Presenting fatherhood as cool, admirable and masculine is likely to headline a new fertility rebound initiative across theAsia Pacific region as birth rates continue to fall at alarming levels. Renowned reproductive endocrinologist Emeritus Professor Domin...

2025-05-06 12:45 2813

Innovent Announces Oral Presentation of Full Phase 2 Clinical Data for Efdamrofusp Alfa (IBI302), First-in-class anti-VEGF/complement Bispecific Fusion Protein at ARVO 2025

SAN FRANCISCO and SUZHOU, China, May 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2025-05-06 08:00 3562

INTREPID Alliance Releases New Report Highlighting Urgent Gaps in Antiviral Preparedness

Global antiviral R&D is slowing when the world can least afford it, new analysis shows CAMBRIDGE, Mass., May 6, 2025 /PRNewswire/ -- The INTREPID Alliance today released the fourth edition of itsAntiviral Clinical and Preclinical Development Landscape, a comprehensive analysis of the global pi...

2025-05-06 02:16 2522

1 ... 112 113 114115116 117 118 ... 540